Publication:
Pharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy

dc.contributor.authorDávila, Guadalupe
dc.contributor.authorMoyano, María Pilar
dc.contributor.authorEdelkraut, Lisa
dc.contributor.authorMoreno-Campos, Lorena
dc.contributor.authorBerthier, Marcelo L.
dc.contributor.authorTorres-Prioris, María José
dc.contributor.authorLópez-Barroso, Diana
dc.contributor.authoraffiliation[Dávila,G; Moyano,MP; Edelkraut,L; Moreno-Campos,L; Berthier,ML; Torres-Prioris,MJ; López-Barroso,D] Cognitive Neurology and Aphasia Unit, Centro de Investigaciones Médico-Sanitarias, University of Malaga, Malaga, Spain. [Dávila,G; Edelkraut,L; Berthier,ML; Torres-Prioris,MJ; López-Barroso,D] Instituto de Investigación Biomédica de Málaga - IBIMA, Málaga, Spain. [Dávila,G; Edelkraut,L; Torres-Prioris,MJ; López-Barroso,D] Department of Psychobiology and Methodology of Behavioural Sciences, Faculty of Psychology and Speech Therapy, University of Malaga, Malaga, Spain. [Dávila,G; Edelkraut,L; Berthier,ML; Torres-Prioris,MJ; López-Barroso,D] Language Neuroscience Research Laboratory, Faculty of Psychology and Speech Therapy, University of Malaga, Malaga, Spain.
dc.date.accessioned2024-02-12T19:46:52Z
dc.date.available2024-02-12T19:46:52Z
dc.date.issued2020-07-31
dc.description.abstractAt present, language therapy is the only available treatment for childhood aphasia (CA). Studying new interventions to augment and hasten the benefits provided by language therapy in children is strongly needed. CA frequently emerges as a consequence of traumatic brain injury and, as in the case of adults, it may be associated with dysfunctional activity of neurotransmitter systems. The use of cognitive-enhancing drugs, alone or combined with aphasia therapy, promotes improvement of language deficits in aphasic adults. In this study we report the case of a 9-year-old right-handed girl, subject P, who had chronic anomic aphasia associated with traumatic lesions in the left temporal-parietal cortex. We performed a single-subject, open-label study encompassing administration of the cholinergic agent donepezil (DP) alone during 12 weeks, followed by a combination of DP and intensive naming therapy (INT) for 2 weeks and thereafter by a continued treatment of DP alone during 12 weeks, a 4-week washout period, and another 2 weeks of INT. Four comprehensive language and neuropsychological evaluations were performed at different timepoints along the study, and multiple naming evaluations were performed after each INT in order to assess performance in treated and untreated words. Structural magnetic resonance imaging (MRI) was performed at baseline. MRI revealed two focal lesions in the left hemisphere, one large involving the posterior inferior and middle temporal gyri and another comprising the angular gyrus. Overall, baseline evaluation disclosed marked impairment in naming with mild-to-moderate compromise of spontaneous speech, repetition, and auditory comprehension. Executive and attention functions were also affected, but memory, visuoconstructive, and visuoperceptive functions were preserved. Treatment with DP alone significantly improved spontaneous speech, auditory comprehension, repetition, and picture naming, in addition to processing speed, selective, and sustained attention. Combined DP-INT further improved naming. After washout of both interventions, most of these beneficial changes remained. Importantly, DP produced no side effects and subject P attained the necessary level of language competence to return to regular schooling. In conclusion, the use of DP alone and in combination with INT improved language function and related cognitive posttraumatic deficits in a child with acquired aphasia. Further studies in larger samples are warranted.
dc.description.sponsorshipMM has been funded by I Plan for Research and Transfer of the University of Malaga (Introduction to Research Scholarship for Undergraduate and Master’s Students, 107/2018). LM-C has been supported by funds from the European Social Fund (E-29-201-0705972). LE has been funded by a PhD scholarship from the Spanish Ministry of Education, Culture, and Sport under the FPU program (FPU17/04136). MT-P has been funded by a postdoctoral fellowship from the University of Malaga. DL-B has been supported by a I+D+i Project, Andalucia and European Union Funds (FEDER) (UMA18-FEDERJA-221). The work was supported in part by the Ministerio de Economía, Industria y Competitividad, Instituto de Salud Carlos III, Madrid, Spain under Grant: PI16/01514.
dc.identifier.doi10.3389/fphar.2020.01144
dc.identifier.e-issn1663-9812es_ES
dc.identifier.journalFrontiers in Pharmacologyes_ES
dc.identifier.otherhttp://hdl.handle.net/10668/3652
dc.identifier.pubmedID32848757es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18088
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fphar.2020.01144/fulles
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectLanguage
dc.subjectChildhood aphasia
dc.subjectAnomia
dc.subjectTraumatic brain injury
dc.subjectDonepezil
dc.subjectPharmacological treatment
dc.subjectIntensive naming therapy
dc.subjectLenguaje
dc.subjectAfasia
dc.subjectLesiones traumáticas del encéfalo
dc.subjectDonepezilo
dc.subjectPreparaciones farmacéuticas
dc.subjectInfancia
dc.subjectPruebas del lenguaje
dc.subjectNiño
dc.subject.meshLanguage
dc.subject.meshAnomia
dc.subject.meshPharmaceutical Preparations
dc.subject.meshLanguage Tests
dc.subject.meshChild
dc.subject.meshHumans
dc.subject.meshSpeech Therapy
dc.subject.meshSpeech
dc.subject.meshLanguage Therapy
dc.subject.meshComprehension
dc.subject.meshAphasia
dc.subject.meshAttention
dc.subject.meshCholinergic Agents
dc.titlePharmacotherapy of Traumatic Childhood Aphasia: Beneficial Effects of Donepezil Alone and Combined With Intensive Naming Therapy
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication9f9fa5ea-093b-43d8-bf2c-5bd65d08a802
relation.isPublisherOfPublication.latestForDiscovery9f9fa5ea-093b-43d8-bf2c-5bd65d08a802

Files